SEPN Septerna Inc Full Business Value
The Septerna Inc (SEPN) price chart demonstrates an Enterprise Value of 1581.72. Septerna Inc fully delegates compound synthesis and clinical testing to external contractors, as it possesses no in-house facilities. The firm's environmental profile is minimal and limited to the disposal of laboratory waste. Growth prospects rely on the success of its GPCR receptor research platform and the support of capital investments in early-stage research.
Septerna Inc (SEPN) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Septerna, Inc. (SEPN)
Septerna Inc (SEPN) is developing innovative drugs for the treatment of endocrine pathologies in the early stages of trials. This Enterprise Value chart visualizes the total business value during the product life cycle formation period. The metric combines market capitalization and net debt, excluding available cash. Such logic determines the actual acquisition price of the company. It is critical for investors to track this metric's dynamics to assess the effectiveness of capitalizing the long-term potential of the assets.
Competitor analysis for Septerna Inc
argenx N.V. - Total Enterprise Value|Total Company Value BioNTech Group|ABVX: Full Business Value|Total Company Value ADMA Biologics|PTGX (protagonist-inc.com) - Business Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|PVLA (Pieris Pharmaceuticals Inc) - Real Price to Acquire Entire Company|Enterprise Value SVRA|Total Company Value Rigel Pharmaceuticals RIGL|Business Value anaptysbio.com (ANAB)|ATXS: Enterprise Value|enGene Holdings Inc - Total Enterprise Value|Total Company Value RAPT (RAPT Therapeutics)|JBIO - Company Buyout Price|Enterprise Value ACRS|KYTX (kyvernatx.com) - Total Enterprise Value|Total Company Value Tiziana Life Sciences Ltd TLSA|Full Business Value Cabaletta Bio Inc. (CABA)|Real Price to Acquire Entire Company Ventyx Bio|Aggregate Business Value Theratechnologies, Inc (THTX)|AVTX: Enterprise Value|eledon.com - Total Enterprise Value|Total Company Value Agenus Inc. (AGEN)|CLYM: Value Adjusted for Debt and Cash|Total Company Value Zura Bio|aTyr Pharmaceuticals (ATYR) - Business Value|ADAG (Adagene Inc) - Enterprise Value|Enterprise Value Ikena Oncology, Inc. (IMA)|Shattuck Labs, Inc. (STTK) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash equilliumbio.com (EQ)|Enterprise Value CNTB|Immunic Therapeutics - Company Buyout Price|Atara Biotherapeutics Inc (ATRA) - Total Company Value|IFRX - Business Value|XFOR (X4 Pharmaceuticals, Inc.) - Enterprise Value|ACET (Adicet Bio, Inc.) - Real Price to Acquire Entire Company|CELU: Total Company Value|Company Buyout Price INmune Bio Corporation|Barinthus Biotherapeutics - Enterprise Value|Total Enterprise Value KZR (kezarlifesciences.com)|SAB Biotherapeutics, Inc. (SABS) - Total Company Value|Akari Therapeutics PLC - Full Business Value|Enlivex Therapeutics, Ltd. (ENLV) - Total Company Value|QTTB: Business Value|Total Company Value GeoVax Labs, Inc. (GOVX)|edesabiotech.com (EDSA) - Full Business Value|IBIO - Enterprise Value|Value Adjusted for Debt and Cash Carisma Tx|Enterprise Value XTLB|Enterprise Value BOLT (boltbio.com)|Total Company Value HCW Biologics|Aptevo Therapeutics, Inc. - Value Adjusted for Debt and Cash|AIM: Total Company Value|ADTX - Real Price to Acquire Entire Company|GRI: Enterprise Value|Enterprise Value XORTX Corp|HIND - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash revbiosciences.com|INDP (Indaptus Therapeutics, Inc.) - Enterprise Value|Company Buyout Price SCNI (Scinai Immunotherapeutics Ltd)|CalciMedica - Total Company Value|Affimed NV - Real Price to Acquire Entire Company|ALLK: Total Company Value|HOOKIPA Pharma Inc. (HOOK) - Real Price to Acquire Entire Company|IGMS: Real Price to Acquire Entire Company|ITOS (iTeos Therapeutics Inc) - Enterprise Value|Total Company Value Ocean Bio (OCEA)|Business Value TC BioPharm Ltd|Third Harmonic Bio - Enterprise Value